27 assets in Fatty Liver Disease

Therapeutic assets addressing Fatty Liver Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dolutegravir Fatty Liver Disease	Fundacion SEIMC-GESIDA	P4	BB (68)
Empagliflozin Fatty Liver Disease	Seoul National University Bundang Hospital	P4	BB (68)
Pioglitazone Fatty Liver Disease	Seoul National University Bundang Hospital	P4	BB (68)
Rilpivirine Fatty Liver Disease	Fundacion SEIMC-GESIDA	P4	BB (68)
(±)-Ftc Fatty Liver Disease	Fundacion SEIMC-GESIDA	P4	BB (66)
Tenofovir Alafenamide Fatty Liver Disease	Fundacion SEIMC-GESIDA	P4	BB (66)
Ertugliflozin Fatty Liver Disease	Getz Pharma	P4	BB (65)
Testosterone Undecylate Fatty Liver Disease	Alexandra Kautzky-Willer	P4	B (62)
Tenofovir Disoproxil Fumarate Fatty Liver Disease	Fundacion SEIMC-GESIDA	P4	B (61)
Amino Acids,Essential Fatty Liver Disease	University of Colorado, Denver	P3	B (60)
Chazhu Xiaozhi Decoction Fatty Liver Disease	Shanghai Municipal Hospital of Traditional Chinese Medicine	P2	B (57)
Tesamorelin Fatty Liver Disease	Hudson Biotech	P2	CCC (55)
coq10 Fatty Liver Disease	Ain Shams University	P2	CCC (53)
Dynamos Fatty Liver Disease	Yale University	P2	CCC (53)
hu6 Fatty Liver Disease	Rivus Pharmaceuticals, Inc.	P2	CCC (53)
Maltodextrin Fatty Liver Disease	McMaster University	P2	CCC (53)
Multiple Vitamins Injection Fatty Liver Disease	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	P2	CCC (53)
N-(P-(2-(Dimethylamino)Ethoxy)Benzyl)Veratramide Fatty Liver Disease	October 6 University	P2	CCC (53)
Gip Fatty Liver Disease	Dr Adnan Agha	P1/2	CCC (48)
rtx001 Fatty Liver Disease	Resolution Therapeutics Limited	P1/2	CCC (48)
Esomeprazole Fatty Liver Disease	Sadat City University	P1/2	CC (47)
Cilostazol Fatty Liver Disease	Tanta University	P1/2	CC (45)
Erdosteine Fatty Liver Disease	Tanta University	P1/2	CC (45)
nnc4005-001 Fatty Liver Disease	Novo Nordisk A/S	P1	CC (43)
Semaglutide Fatty Liver Disease	Insel Gruppe AG, University Hospital Bern	N/A	D (30)
Ursodeoxycholic Acid Fatty Liver Disease	Phenomen Pharma	N/A	D (30)
Longqi Jiangzhi Decoction Fatty Liver Disease	Shanghai Municipal Hospital of Traditional Chinese Medicine	P2	NR ()